As Halloween approaches, anticipation for trick-or-treating grows, and with it, the annual harvest of millions of cocoa beans used to make delightful chocolates. However, amidst the production of chocolate, the shells of these beans are discarded. Now, researchers unveil the potential of cocoa pod shells as a valuable starting material for flame retardants. It is… Seguir leyendo Cocoa pods – source of chocolate and possible flame retardant
Many people who think they are allergic to penicillin are not
The Royal Pharmaceutical Society has issued a warning that approximately 6% of individuals in the UK are erroneously labeled as allergic to penicillin in their medical records. This statistic raises concerns as those mislabeled with an allergy to this potent antibiotic face a mortality rate of 6 in every 1,000 patients annually after infection treatment.… Seguir leyendo Many people who think they are allergic to penicillin are not
Common diabetes drug may treat gum disease and aid healthy aging
In a recent article published in the Journal of Translational Medicine, a team of researchers from the College of Dental, Oral, and Craniofacial Sciences has unveiled a novel method to combat periodontal (gum) disease and potentially reduce the incidence of diabetes and obesity. This innovative approach centers around utilizing the common Type 2 diabetes drug,… Seguir leyendo Common diabetes drug may treat gum disease and aid healthy aging
FDA approves Voquezna for erosive esophagitis, gastroesophageal reflux disease
In a significant milestone, the U.S. Food and Drug Administration (FDA) has greenlit Phathom Pharmaceuticals’ revolutionary therapy, Voquezna (vonoprazan), heralding a new era in the treatment landscape for erosive esophagitis (EE) and gastroesophageal reflux disease (GERD) among adults. The nod comes on the heels of the PHALCON-EE Phase III trial, where Voquezna 20 mg showcased… Seguir leyendo FDA approves Voquezna for erosive esophagitis, gastroesophageal reflux disease
Can new antibiotic chloropeptide defeat superbugs? Or will it join a long list of failed drugs?
In a world where even a simple infection poses a life-threatening risk, and a minor wound could lead to catastrophe, the effective treatment of diseases has become an increasingly challenging task for doctors. This is not a scenario from a science fiction movie but a real and pressing issue. For decades, antibiotics have been crucial… Seguir leyendo Can new antibiotic chloropeptide defeat superbugs? Or will it join a long list of failed drugs?
Dependence-free pain relief
In recent times, attention has centered on the use of opioid medications, including morphine and related analgesics like hydrocodone. While considered a blessing for patients experiencing severe and acute pain, the potential for addiction and the risk of fatal overdose also pose a significant challenge. The opioid crisis, claiming thousands of lives annually in the… Seguir leyendo Dependence-free pain relief
Engineers develop vibrating, ingestible capsule that may help treat obesity
Scientists at the Massachusetts Institute of Technology (MIT) have devised a groundbreaking approach to harness the signals sent from the stomach to the brain during a meal. Their method involves an ingestible capsule that vibrates within the stomach, activating stretch receptors to create a perceived sense of fullness. Published in “Scientific Advances,” the team’s research… Seguir leyendo Engineers develop vibrating, ingestible capsule that may help treat obesity
Treating opioids without medication is more harmful than no treatment at all, study finds
A recent study led by Yale University sheds light on the effectiveness of short-term medical management (commonly known as detox) and long-term rehabilitation treatments, excluding continued use of naltrexone or methadone, in preventing overdose deaths in cases of opioid use disorders. Researchers emphasize the significance of sustained medication therapy for opioid use disorders, advocating for… Seguir leyendo Treating opioids without medication is more harmful than no treatment at all, study finds
Wegovy: Why half of people who take it stop taking it within a year, and what happens when they stop taking it
While the new generation of anti-obesity drugs, known as GLP-1 receptor agonists, proves effective, long-term adherence remains a challenge. A recent study in the “Obesity” journal reveals that only 44% of individuals using weight-loss medications continue after three months, dropping to 19% after a year. Enhanced adherence, as seen with medications like Wegovy, results in… Seguir leyendo Wegovy: Why half of people who take it stop taking it within a year, and what happens when they stop taking it
The EU’s new batch of apple cell cultures, technology is becoming the direction of raw material iteration
On August 3rd, the European Food Safety Authority (EFSA) granted approval for “Apple Cell Culture Biomass” as a Novel Food. The approved ingredient, PhytoCellTec™ Md Nu, belongs to the Swiss raw material supplier Mibelle Biochemistry. Initially used in cosmetics, it has expanded its applications to the food and beverage and dietary supplement sectors. The Application… Seguir leyendo The EU’s new batch of apple cell cultures, technology is becoming the direction of raw material iteration
Spanish 
English